Synthesis and in vitro antimicrobial studies of medicinally important novel N-alkyl and N-sulfonyl derivatives of 1-[bis(4-fluorophenyl)-methyl]piperazine

被引:61
作者
Chandra, J. N. Narendra Sharath [1 ]
Sadashiva, C. T. [1 ]
Kavitha, C. V. [1 ]
Rangappa, K. S. [1 ]
机构
[1] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India
关键词
1-[bis(4-fluorophenyl)-methyl]piperazine derivatives; antibacterial; paper disc diffusion method; minimum inhibitory concentration;
D O I
10.1016/j.bmc.2006.05.064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of novel substituted 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives (4a-g) and (5h-m) have been synthesized. The synthesized compounds were characterized by IR and H-1 NMR. All the synthesized compounds were evaluated in vitro for their efficacy as antimicrobial agents against representative strains of Gram-positive (Staphylococcus aureus ATCC 25953, Streptococcus pneumoniae ATCC 49619, Bacillus cereus 11778, and Bacillus subtilis 6051) and Gram-negative bacteria (Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 2853, Proteus vulgaris ATCC 2853, and Salmonella typhi ATCC 9484) by paper disc diffusion and microdilution methods. Among the newly synthesized compounds 4e, 51, and 5m showed potent antimicrobial activities, when compared to the standard drug. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6621 / 6627
页数:7
相关论文
共 15 条
  • [1] Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: Applying a "divide and conquer" strategy
    Amin, EA
    Welsh, WJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (23) : 3849 - 3855
  • [2] The fluoroquinolone antibacterials: past, present and future perspectives
    Appelbaum, PC
    Hunter, PA
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (01) : 5 - 15
  • [3] HIGHLY DIASTEREOSELECTIVE REACTION OF A CHIRAL, NON-RACEMIC AMIDE ENOLATE WITH (S)-GLYCIDYL TOSYLATE - SYNTHESIS OF THE ORALLY-ACTIVE HIV-1 PROTEASE INHIBITOR L-735,524
    ASKIN, D
    ENG, KK
    ROSSEN, K
    PURICK, RM
    WELLS, KM
    VOLANTE, RP
    REIDER, PJ
    [J]. TETRAHEDRON LETTERS, 1994, 35 (05) : 673 - 676
  • [4] Ball P, 2000, J ANTIMICROB CHEMOTH, V46, P17
  • [5] Synthesis and antimicrobial activity of N-alkyl and N-aryl piperazine derivatives
    Chaudhary, P
    Kumar, R
    Verma, AK
    Singh, D
    Yadav, V
    Chhillar, AK
    Sharma, GL
    Chandra, R
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (06) : 1819 - 1826
  • [6] Amphotericin B-induced nephrotoxicity: A review
    Fanos, V
    Cataldi, L
    [J]. JOURNAL OF CHEMOTHERAPY, 2000, 12 (06) : 463 - 470
  • [7] GRASELA TH, 1990, PHARMACOTHERAPY, V10, P341
  • [8] Novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter
    Kimura, M
    Masuda, T
    Yamada, K
    Mitani, M
    Kubota, N
    Kawakatsu, N
    Kishii, K
    Inazu, M
    Kiuchi, Y
    Oguchi, K
    Namiki, T
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (18) : 3953 - 3963
  • [9] OHTAKA H, 1987, CHEM PHARM BULL, V35, P3270
  • [10] Synthesis and characterization of novel 6-fluoro-4-piperidinyl-1,2-benzisoxazole amides and 6-fluoro-chroman-2-carboxamides: antimicrobial studies
    Priya, BS
    Basappa
    Swamy, SN
    Rangappa, KS
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (07) : 2623 - 2628